Caris Life Sciences, Inc. Common Stock Cash Flow Reinvestment Rate
Caris Life Sciences, Inc. Common Stock cash flow reinvestment rate. Caris Life Sciences, Inc. Common Stock (CAI) has a Cash Flow Reinvestment Rate of 0.53x as of June 2026, reinvesting $32.42 Million (capex $32.42 Million ) from operating cash flow of $61.35 Million. Explore CAI operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Caris Life Sciences, Inc. Common Stock (2005–2025)
Cash flow reinvestment rate of Caris Life Sciences, Inc. Common Stock from 2005 to 2025. Historical reinvestment intensity for Caris Life Sciences, Inc. Common Stock across 16 annual periods. Explore CAI capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Caris Life Sciences, Inc. Common Stock Cash Flow Reinvestment Rate by Year (2005–2025)
Caris Life Sciences, Inc. Common Stock cash flow reinvestment rate by year from 2005 to 2025. Year-by-year capital reinvestment analysis for Caris Life Sciences, Inc. Common Stock. For the full cash flow conversion analysis, see CAI cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | $16.26 Million | $83.16 Million | $16.26 Million | ▼ -75.3% |
| 2020 | 0.79x | $219.45 Million | $277.02 Million | $219.45 Million | ▼ -37.0% |
| 2019 | 1.26x | $319.14 Million | $254.00 Million | $319.14 Million | ▼ -72.2% |
| 2018 | 4.52x | $812.84 Million | $179.77 Million | $812.84 Million | ▲ +39.7% |
| 2017 | 3.24x | $502.18 Million | $155.19 Million | $502.18 Million | ▲ +66.5% |
| 2016 | 1.94x | $251.25 Million | $129.26 Million | $251.25 Million | ▼ -26.4% |
| 2015 | 2.64x | $389.41 Million | $147.37 Million | $389.41 Million | ▲ +20.1% |
| 2014 | 2.20x | $307.31 Million | $139.69 Million | $307.31 Million | ▼ -12.5% |
| 2013 | 2.51x | $312.20 Million | $124.19 Million | $312.20 Million | ▼ -48.8% |
| 2012 | 4.91x | $524.60 Million | $106.83 Million | $524.60 Million | ▼ -28.0% |
| 2011 | 6.82x | $491.93 Million | $72.11 Million | $491.93 Million | ▲ +39.9% |
| 2010 | 4.88x | $206.83 Million | $42.42 Million | $206.83 Million | ▲ +378.9% |
| 2009 | 1.02x | $31.35 Million | $30.80 Million | $31.35 Million | ▼ -86.3% |
| 2008 | 7.45x | $204.30 Million | $27.44 Million | $204.30 Million | ▲ +36.0% |
| 2006 | 5.47x | $45.85 Million | $8.38 Million | $45.85 Million | ▲ +45910.8% |
| 2005 | 0.01x | $350.00K | $29.41 Million | $350.00K | — |